In English | En español
Questions About Cancer? 1-800-4-CANCER

Kaposi Sarcoma Treatment (PDQ®)

  • Last Modified: 04/04/2011

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

Changes to This Summary (04/04/2011)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Kaposi Sarcoma

Added Lodi et al. as reference 19.

Epidemic Kaposi Sarcoma

Added text to state that during highly active antiretroviral therapy, both pegylated liposomal doxorubicin and paclitaxel are active single agents with response rates close to 50% (cited Cianfrocca et al. as reference 17 and level of evidence 1iiDiv).